Clinical Trials
69 trialsROXI-CAT-I
Regeneron Pharmaceuticals
STAT-CAT
Brigham and Women's Hospital
HOME-PEK
Assistance Publique - Hôpitaux de Paris
MAGNOLIA
Anthos Therapeutics, Inc.
Apixaban in Thrombocytopenia
Beth Israel Deaconess Medical Center
ROXI-CAT-II
Regeneron Pharmaceuticals
ASTER
Anthos Therapeutics, Inc.
CATforCAT
Centre Hospitalier Universitaire de Saint Etienne
CATIQ P3
Quercis Pharma AG
HEM-DOAC
Medical University of Gdansk
HYDRA
Leiden University Medical Center
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
Brigham and Women's Hospital
IPVB and POCs
Tongji Hospital
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
Medical University of South Carolina
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Academic and Community Cancer Research United
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
ChromX Health
ELEVATE
Prisma Health-Midlands
PREPOSTEROUS
Helsinki University Central Hospital
Pulmonary Thromboembolism in Cancer Patients: Early Rule-out From the Emergency Department
IRCCS Azienda Ospedaliero-Universitaria di Bologna
MVTEP2/SOME2
University Hospital, Brest
EPLLMMRDC
North Sichuan Medical College
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
Thunder Bay Regional Health Research Institute
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
First Affiliated Hospital Xi'an Jiaotong University
Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
University of Zurich
Personalized Anticoagulant Therapy for Pulmonary Thromboembolism
Xiangya Hospital of Central South University
On Dose Efficiency of Modern CT-scanners in Chest Scans
University Hospital Augsburg
COSIMO
Bayer
CANVAS
Alliance Foundation Trials, LLC.
VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program
Nordsjaellands Hospital
ACTIV4
Eurasian Association of Therapists
The Incidence of Pulmonary Embolism During Nephrectomy
Mahidol University
Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
Ottawa Hospital Research Institute
Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
M.D. Anderson Cancer Center
PAP-UP
Thomas Jefferson University
SOME-RIETE
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
LISSE1
Centre Hospitalier Régional d'Orléans
Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study
University of Utah
CHIPs-VTE Study in Hospitalized Patients With Lung Cancer
China-Japan Friendship Hospital
Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection
McMaster University
Prevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology Patients
Hellenic Society of Medical Oncology
PREVENTER
Johns Hopkins University
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
G. d'Annunzio University
A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
The University of Hong Kong
Cancer Venous Thromboembolism (VTE)
Daiichi Sankyo
ALICAT
Cardiff University
Venous Thromboembolic Complications in Ovarian Cancer
Aalborg University Hospital
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
McMaster University
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
VA Greater Los Angeles Healthcare System
REMARK
Ottawa Hospital Research Institute